Trial Profile
A Single-center, Open, Phase I Clinical Trial to Evaluate Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2021
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A B C Y W-135 conjugate (Primary)
- Indications Meningococcal group A infections; Meningococcal group B infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections
- Focus Adverse reactions
- Sponsors Beijing Zhifei Lvzhu Biopharmaceutical
- 07 Sep 2016 New trial record